Avita Lands Government Contract Worth Up to $25.5M to Supply RECELL Products

Dow Jones
Apr 09

By Christopher Kuo

 

Avita Medical entered an agreement worth up to $25.5 million with a research unit of the Department of Health and Human Services to supply the government with treatments for burn mass casualty incidents.

During the 10-year contract, Avita, a wound care company, will grant the Biomedical Advanced Research and Development Authority access to 3,000 units of its RECELL products, which are FDA-approved treatments for thermal burns and trauma wounds, the company said Wednesday.

BARDA is part of the Administration for Strategic Preparedness and Response within the Health Department.

In the event of a burn mass casualty incident, the RECELL products would be deployed to designated centers with trained staff. Avita will also provide BARDA with logistics help, quality assurance and deployment readiness, the company said.

 

Write to Chris Kuo at chris.kuo@wsj.com

 

(END) Dow Jones Newswires

April 08, 2026 17:01 ET (21:01 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10